CNBC   |  April 11, 2013

Eli Lilly CEO on the Future of Big Pharma

John Lechleiter, chairman, president & CEO of Eli Lilly, discusses which new drugs are in the company's pipeline as its stock nears 52-week highs.

Share This:

Sorry, we do not have a transcript available for this video at this time.